Literature DB >> 22505867

Topiramate-induced somnambulism in a migraineur: a probable idiosyncratic adverse effect.

Thomas Mathew1, G R K Sarma, Raghunandan Nadig, Raji Varghese.   

Abstract

Somnambulism (sleepwalking) is a disorder of arousal that falls under "parasomnia" group and is more common in children. These phenomena occur as primary sleep events or secondary to systemic disease or can be drug induced. Medications that can cause sleepwalking include neuroleptics, hypnotics, lithium, amitriptyline, and β-blockers. This report presents an unusual adverse effect of topiramate on sleep in a patient with migraine.

Entities:  

Keywords:  Topiramate; adverse effect; idiosyncratic reaction; migraine; somnambulism

Mesh：

Substances：

Year:  2012        PMID： 22505867      PMCID： PMC3311419          DOI： 10.5664/jcsm.1782

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN： 1550-9389            Impact factor:   4.062


  8 in total

1.  Topiramate induced somnabulism and automatic behaviour.

Authors:  B M Varkey; L M Varkey
Journal:  Indian J Med Sci       Date:  2003-11

2.  Migraine and somnambulism.

Authors:  Olivier Casez; Yannick Dananchet; Gérard Besson
Journal:  Neurology       Date:  2005-10-25       Impact factor: 9.910

Review 3.  Factors that predispose, prime and precipitate NREM parasomnias in adults: clinical and forensic implications.

Authors:  Mark R Pressman
Journal:  Sleep Med Rev       Date:  2007-02       Impact factor: 11.609

4.  Differential modulation of high-frequency gamma-electroencephalogram activity and sleep-wake state by noradrenaline and serotonin microinjections into the region of cholinergic basalis neurons.

Authors:  E G Cape; B E Jones
Journal:  J Neurosci       Date:  1998-04-01       Impact factor: 6.167

5.  Treatment of nocturnal eating syndrome and sleep-related eating disorder with topiramate.

Authors:  John W Winkelman
Journal:  Sleep Med       Date:  2003-05       Impact factor: 3.492

6.  Comparison of the effects of vigabatrin, lamotrigine, and topiramate on quantitative EEGs in patients with epilepsy.

Authors:  M Y Neufeld; E Kogan; V Chistik; A D Korczyn
Journal:  Clin Neuropharmacol       Date:  1999 Mar-Apr       Impact factor: 1.592

7.  Topiramate effects on plasma serotonin levels in children with epilepsy.

Authors:  Salvatore Grosso; Patrizia Blardi; Marco Battaglini; Emilio Franzoni; Arianna De Lalla; Rosa Mostardini; Paolo Balestri
Journal:  Epilepsy Res       Date:  2008-07-07       Impact factor: 3.045

8.  Riluzole, a glutamate antagonist, enhances slow wave and REM sleep in rats.

Authors:  J M Stutzmann; M Lucas; J C Blanchard; P M Laduron
Journal:  Neurosci Lett       Date:  1988-05-26       Impact factor: 3.046
  8 in total
  1 in total

1.  Somnambulism During Monotherapy With Mixed Amphetamine Salts.

Authors:  Subhash Pinnaka; Khrisan Gosai; Cezary Czekierdowski; Pamela P Siller; Kyle A B Lapidus
Journal:  J Clin Psychopharmacol       Date:  2016-04       Impact factor: 3.153
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.